Wan-Jen Hong
Chief Tech/Sci/R&D Officer bij IMAGO BIOSCIENCES, INC.
Profiel
Wan-Jen Hong is a professional with experience in the biotechnology industry.
Currently, he holds the position of Chief Medical Officer at Imago BioSciences, Inc. and Senior Vice President-Clinical Development at Prelude Therapeutics, Inc. Prior to his current roles, he worked as a Group Medical Director at Genentech, Inc. from 2014 to 2021.
He received his undergraduate degree from Massachusetts Institute of Technology and his doctorate from Stanford University School of Medicine.
Actieve functies van Wan-Jen Hong
| Bedrijven | Functie | Begin |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01-05-2021 |
| PRELUDE THERAPEUTICS INCORPORATED | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Wan-Jen Hong
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01-01-2021 |
Opleiding van Wan-Jen Hong
| Massachusetts Institute of Technology | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
